Mersana Therapeutics, Inc.

Home » Mersana Therapeutics, Inc.

IPO

Mersana Therapeutics, Inc.

They are a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.

Symbol

MRSN

Price Range
$14.00 - $16.00

Anticipated Shares
5,000,000

Anticipated Date
TBD

Underwriters
J.P. Morgan, Cowen and Company, Leerink Partners, Wedbush PacGrow

To view the prospectus for Mersana Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253